Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.91% | -2.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.91% | -2.31% | |||
| Cost of Revenue | 10.22% | 0.05% | |||
| Gross Profit | 4.93% | -5.19% | |||
| SG&A Expenses | 5.43% | 6.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.87% | 4.24% | |||
| Operating Income | -0.58% | -75.03% | |||
| Income Before Tax | -78.57% | -59.08% | |||
| Income Tax Expenses | -372.18% | 133.08% | |||
| Earnings from Continuing Operations | -73.95% | -69.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -73.95% | -69.17% | |||
| EBIT | -0.58% | -75.03% | |||
| EBITDA | -6.20% | -540.72% | |||
| EPS Basic | -73.17% | -68.88% | |||
| Normalized Basic EPS | -1.59% | -87.91% | |||
| EPS Diluted | -73.17% | -68.88% | |||
| Normalized Diluted EPS | -1.59% | -87.91% | |||
| Average Basic Shares Outstanding | 0.45% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||